Search by Drug Name or NDC

NDC 63759-3048-01 Pemetrexed 100 mg/10mL Details

Pemetrexed 100 mg/10mL

Pemetrexed is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by SHILPA MEDICARE LIMITED. The primary component is PEMETREXED DISODIUM HEMIPENTAHYDRATE.

MedlinePlus Drug Summary

Pemetrexed injection is used in combination with other chemotherapy medications as a first treatment for a certain type of non-small cell lung cancer (NSCLC) that has spread to nearby tissues or to other parts of the body. Pemetrexed injection is also used alone to treat NSCLC as ongoing treatment in people who have already received certain chemotherapy medications and whose cancer has not worsened and in people who could not be treated successfully with other chemotherapy medications. Pemetrexed injection is also in combination with another chemotherapy medication as a first treatment for malignant pleural mesothelioma (a type of cancer that affects the inside lining of the chest cavity) in people who cannot be treated with surgery. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by blocking the action of a certain substance in the body that may help cancer cells multiply.

Related Packages: 63759-3048-01
Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Pemetrexed Injection

Product Information

NDC	63759-3048
Product ID	63759-3048_8e36994a-0455-44ab-9ccc-02eaa0ec5699
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Pemetrexed
Proprietary Name Suffix	n/a
Non-Proprietary Name	Pemetrexed disodium
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION
Route	INTRAVENOUS
Active Ingredient Strength	100
Active Ingredient Units	mg/10mL
Substance Name	PEMETREXED DISODIUM HEMIPENTAHYDRATE
Labeler Name	SHILPA MEDICARE LIMITED
Pharmaceutical Class	Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA215179
Listing Certified Through	2024-12-31

Package

NDC 63759-3048-01 (63759304801)

Pricing Information	N/A
NDC Package Code	63759-3048-1
Billing NDC	63759304801
Package	1 VIAL in 1 CARTON (63759-3048-1) / 10 mL in 1 VIAL
Marketing Start Date	2023-06-03
NDC Exclude Flag	N